Arry stock analysis

2019-12-08 04:54

Array BioPharma Inc. (ARRY) (Real Time Quote from BATS) The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. The scores areAt Yahoo Finance, you get free stock quotes, uptodate news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. arry stock analysis

View the basic ARRY stock chart on Yahoo Finance. Change the date range, chart type and compare Array BioPharma Inc. against other companies.

It is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its clinical stage drugs include Binimetinib, Encorafenib, Selumetinib, TucatinibONT380, ARRY382, Analyze Array BioPharma Inc. (ARRY) using the investment criteria of some of the greatest guru investors of our time. arry stock analysis Array BioPharma Inc. stock price, stock quotes and financial overviews from MarketWatch.

Array BioPharma Inc. Stock Analysis. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by 0. 14 million shares and in total 2. 69 million shares bought and sold for approximately 37. 98 million. arry stock analysis Feb 16, 2019  Updated analyst estimates for Array BioPharma Inc. including ARRY earnings per share estimates and analyst recommendations. Mattel boomerangs to its worst stock Latest Breaking news and Headlines on Array BioPharma Inc. (ARRY) stock from Seeking Alpha. Read the news as it happens!

Rating: 4.70 / Views: 347